E-LIB Suche - Ergebnisse für: Sofen, H.

1

Covalent capture and electrochemical quantification of path..:

Klass, Sarah H. ; Sofen, Laura E. ; Hallberg, Zachary F....
Chemical Communications. 57 (2021) 20 - p. 2507-2510 , 2021

2

Three‐year efficacy and safety of certolizumab pegol for th..:

Warren, R. B. ; Lebwohl, M. ; Sofen, H....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 12 - p. 2398-2408 , 2021

Link: https://doi.org/10.1111/..

3

A reliability study using Network-Oriented Research Assista..:

Hughes, Meagan E. ; Aralis, Hilary ; Bruhn, Kevin W....
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. 725-726 , 2021

Link: https://doi.org/10.1016/..

4

Efficacy and safety of apremilast in patients with moderate..:

Van Voorhees, A.S. ; Stein Gold, L. ; Lebwohl, M....
British Journal of Dermatology. 185 (2021) 4 - p. 840-842 , 2021

Link: https://doi.org/10.1111/..

5

Covalent capture and electrochemical quantification of path..:

Klass, Sarah H ; Sofen, Laura E ; Hallberg, Zachary F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274617/. , 2021

Link: http://www.ncbi.nlm.nih...

6

Three‐year efficacy and safety of certolizumab pegol for th..:

Warren, RB ; Lebwohl, M ; Sofen, H...
qt60q8t66g. , 2021

Link: https://escholarship.org..

7

Three‐year efficacy and safety of certolizumab pegol for th..:

Warren, R. B ; Lebwohl, M ; Sofen, H...
https://chesterrep.openrepository.com/bitstream/handle/10034/625613/jdv.17486.xml?sequence=2. , 2021

Link: http://hdl.handle.net/10..

8

Three‐year efficacy and safety of certolizumab pegol for th..:

Warren, R. B ; Lebwohl, M ; Sofen, H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290019/. , 2021

Link: http://www.ncbi.nlm.nih...

9

Covalent capture and electrochemical quantification of path..:

Klass, Sarah H ; Sofen, Laura E ; Hallberg, Zachary F...
qt31m2z574. , 2021

Link: https://escholarship.org..

10

Covalent capture and electrochemical quantification of path..:

Klass, Sarah H ; Sofen, Laura E ; Hallberg, Zachary F...
10.1039/d0cc08420d. , 2021

Link: https://hdl.handle.net/1..

11

Efficacy and safety of apremilast in patients with moderate..:

Van Voorhees, A.S ; Stein Gold, L ; Lebwohl, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518877/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Dose Adjustment Patterns in the Open-Label Extension Arms o..:

Blauvelt, A ; Gottlieb, AB ; Fierens, F...
SKIN The Journal of Cutaneous Medicine. 4 (2020) 6 - p. s85 , 2020

Link: https://doi.org/10.25251..

13

The Efficacy of Certolizumab Pegol Re-Treatment on Plaque P..:

Lebwohl, M ; Piguet, V ; Sofen, H.
SKIN The Journal of Cutaneous Medicine. 3 (2019) 2 - p. 174 , 2019

Link: https://doi.org/10.25251..

14

Efficacité du certolizumab pegol en retraitement du psorias..:

Khemis, A. ; Lebwohl, M. ; Piguet, V....
Annales de Dermatologie et de Vénéréologie. 146 (2019) 12 - p. A340-A341 , 2019

Link: https://doi.org/10.1016/..

15

Incidence of serious gastrointestinal events among tildraki..:

Gooderham, M. ; Elewski, B.E. ; Pariser, D.M....
Journal of the European Academy of Dermatology and Venereology. 33 (2019) 10 - p. , 2019

Link: https://doi.org/10.1111/..